Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs

Introduction: Access to and the cost of induction treatment for cryptococcal meningitis (CM) is rapidly changing. The newly-announced price for flucytosine ($0.75 per 500 mg pill) and possibly lower prices for liposomal amphotericin B (AmB-L) create opportunities to reduce CM treatment costs compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Larson, Bruce, Shroufi, Amir, Muthoga, Charles, Oladele, Rita, Rajasingham, Radha, Jordan, Alexander, Jarvis, Joseph N., Chiller, Tom M., Govender, Nelesh P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184925/
https://www.ncbi.nlm.nih.gov/pubmed/35706922
http://dx.doi.org/10.12688/wellcomeopenres.16776.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184925/
https://www.ncbi.nlm.nih.gov/pubmed/35706922
http://dx.doi.org/10.12688/wellcomeopenres.16776.3

Ejemplares similares